Lymphopenia: Clinical Trials

2 trials for Lymphopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
Gammaplex (Intravenous immunoglobulin) - Primary Immunodeficiency, Common Variable Hypogammaglobulinemia
Phase 3CompletedBio Products Laboratory502006-01-012013-01-24
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified, Dextrose, 5% in Water - Immunologic Deficiency Syndrome, Agammaglobulinemia
Phase 3CompletedGrifols Therapeutics LLC1002002-08-012009-09-25

Narrower conditions

Agammaglobulinemia (2)  ·  Common Variable Immunodeficiency (2)  ·  Primary Immunodeficiency Diseases (2)  ·  Wiskott-Aldrich Syndrome (2)  ·  Hyper-IgM Immunodeficiency Syndrome (1)  ·  Hypogammaglobulinemia, X-Linked (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Severe Combined Immunodeficiency (1)

Broader conditions

Blood Coagulation Disorders (2)  ·  Blood Coagulation Disorders, Inherited (2)  ·  Blood Protein Disorders (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Cytopenia (2)  ·  Genetic Diseases, Inborn (2)  ·  Genetic Diseases, X-Linked (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Immune System Diseases (2)  ·  Leukocyte Disorders (2)  ·  Leukopenia (2)  ·  Lymphatic Diseases (2)

Interventions

Immunoglobulins, Intravenous (2)  ·  gamma-Globulins (2)  ·  Caprylates (1)  ·  Glucose (1)  ·  Water (1)

Sponsors

Bio Products Laboratory (1)  ·  Grifols Therapeutics LLC (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Erwin Gelfand, MD (1)  ·  Melvin Berger, MD (1)

Results publications

PMID 36818468